Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jessica Kiszka

Nurse Practitioner, Gerontology Munster, IN Nurse Practitioner

NPI 1336554898 CMS profile 11231642

9104 Columbia Ave, Munster, IN 46321

Open in the dashboard

General payments

$42,138

351 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jessica Kiszka of Munster, IN is reported in the CMS Open Payments database as having received $42,138 across 351 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Gerontology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $123 7
2024 General $221 16
2023 General $436 19
2022 General $33,568 208
2021 General $7,791 101

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jessica Kiszka
  • Nurse Practitioner, Gerontology median
  • Middle half of Nurse Practitioner, Gerontology
  • National median

In program year 2025, general payments to Jessica Kiszka were reported at $123. Among 4,139 Nurse Practitioner, Gerontology profiles paid that year, the median was $179 and the middle half received between $55 and $547.

Show as a table
Year Jessica Kiszka Nurse Practitioner, Gerontology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $7,791 $133 $44–$396 $132
2022 $33,568 $142 $48–$452 $149
2023 $436 $158 $53–$482 $160
2024 $221 $171 $55–$533 $164
2025 $123 $179 $55–$547 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $37,891 187 payments
  2. Edwards Lifesciences Corporation $1,337 25 payments
  3. Novartis Pharmaceuticals Corporation $794 56 payments
  4. Boston Scientific Corporation $513 11 payments
  5. Abbott Laboratories $339 7 payments
  6. Amgen Inc. $180 11 payments
  7. Cardiovascular Systems Inc. $178 2 payments
  8. Biotronik Inc. $173 3 payments
  9. Janssen Pharmaceuticals, Inc $149 8 payments
  10. Merck Sharp & Dohme Corporation $136 10 payments
  11. Other $449 31 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,670 21 payments
  2. Food and Beverage $10,982 290 payments
  3. Travel and Lodging $6,487 40 payments
Products named General payments · program years 2021–2025
  1. COREVALVE EVOLUT R $32,299 155 payments
  2. CoreValve Evolut $5,408 30 payments
  3. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $1,260 22 payments
  4. LEQVIO Cardiology/Vascular Diseases $568 39 payments
  5. WATCHMAN Access System $322 6 payments
  6. LEQVIO Cardiovascular $201 15 payments
  7. WATCHMAN $181 2 payments
  8. Repatha $180 11 payments
  9. Diamondback Coronary $178 2 payments
  10. MITRACLIP $165 4 payments
  11. Other $1,111 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

351 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record